COMPARISON OF INTRAVENOUS VERSUS ORAL PARACETAMOL IN PRETERM NEONATES WITH PATENT DUCTUS ARTERIOSUS
DOI:
https://doi.org/10.70520/kjms.v18i3.777Keywords:
Efficacy, Paracetamol, PDA, EchocardiographyAbstract
Objective: The aim of the study was to compare the efficacy of oral route versus intravenous paracetamol in promoting ductal closure in preterm neonates.
Materials and Methods: This cross-sectional study was carried out in the Pediatrics Department of the Lady Reading Hospital, Peshawar. In case of unavailability of paracetamol, ibuprofen was kept as an alternative option ensuring continuity of care without compromising ethical or treatment standards. Baseline demographic details were recorded, and at the completion of treatment, the outcome in terms of PDA closure was noted. Data analysis was done using SPSS latest version, with the chi-square test applied for comparing efficacy of paracetamol between groups.
Results: Oral paracetamol achieved higher PDA closure rates than intravenous therapy (80.5% vs. 67.5%). Closure was significantly greater in infants aged 32–34 weeks (p = 0.02) and in those with parents having secondary education (p = 0.03). A non-significant trend toward better outcomes was observed in females (p = 0.07), while socioeconomic status (p = 0.91) and neonatal weight (p = 0.88) had no effect.
Conclusion: Oral paracetamol was more effective than intravenous paracetamol in promoting PDA closure in specific subgroups, particularly in neonates aged 32–34 weeks and those with parents having secondary education. This is essential as both educational and socioeconomic status are relevant as they can indirectly influence neonatal outcomes through factors such as timely access to treatment, antenatal care and availability of medications.
References
1. Chesi E, Rossi K, Ancora G, Baraldi C, Corradi M, Di Dio F, et al. Patent ductus arteriosus (also non-hemodynamically significant) correlates with poor outcomes in very low birth weight infants. A multicenter cohort study. Plos one. 2024;19(7):e0306769.
2. Köksal N, Aygün C, Uras N. Turkish Neonatal Society guideline on the management of patent ductus arteriosus in preterm infants. Turkish Archives of Pediatrics/Türk Pediatri Ar?ivi. 2018;53(Suppl 1):S76.
3. Jones BM, Kapadia SR, Smedira NG, Robich M, Tuzcu EM, Menon V, et al. Ventricular septal rupture complicating acute myocardial infarction: a contemporary review. European heart journal. 2014;35(31):2060-8.
4. Deng Y, Zhang H, Zhao Z, Du J, Bai R, McNamara PJ. Impact of patent ductus arteriosus shunt size and duration on risk of death or severe respiratory morbidity in preterm infants born in China. European journal of pediatrics. 2022;181(8):3131-40.
5. Mitra S, Florez ID, Tamayo ME, Mbuagbaw L, Vanniyasingam T, Veroniki AA, et al. Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. Jama. 2018;319(12):1221-38.
6. Dimiati H, Darussalam D, Firmansyah I. Intravenous paracetamol and patent ductus arteriosus closure. Journal of Neonatology. 2020(1).
7. Oncel MY, Yurttutan S, Degirmencioglu H, Uras N, Altug N, Erdeve O, et al. Intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants. Neonatology. 2013;103(3):166-9.
8. Hammerman C, Bin-Nun A, Markovitch E, Schimmel MS, Kaplan M, Fink D. Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment. Pediatrics. 2011;128(6):e1618-e21.
9. Bagheri MM, Niknafs P, Sabsevari F, Torabi MH, Bijari BB, Noroozi E, et al. Comparison of oral acetaminophen versus ibuprofen in premature infants with patent ductus arteriosus. Iranian journal of pediatrics. 2016;26(4):e3975.
10. Al-Lawama M, Alammori I, Abdelghani T, Badran E. Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus. Journal of International Medical Research. 2018;46(2):811-8.
11. Ohlsson A, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database of Systematic Reviews. 2018(4).
12. Gover A, Levy PT, Rotschild A, Golzman M, Molad M, Lavie-Nevo K, et al. Oral versus intravenous paracetamol for patent ductus arteriosus closure in preterm infants. Pediatric Research. 2022;92(4):1146-52.
13. Sancak S, Gokmen Yildirim T, Topcuoglu S, Yavuz T, Karatekin G, Ovali F. Oral versus intravenous paracetamol: which is better in closure of patent ductus arteriosus in very low birth weight infants? The Journal of Maternal-Fetal & Neonatal Medicine. 2016;29(1):135-9.
14. Meena V, Meena DS, Rathore PS, Chaudhary S, Soni JP. Comparison of the efficacy and safety of indomethacin, ibuprofen, and paracetamol in the closure of patent ductus arteriosus in preterm neonates–A randomized controlled trial. Annals of Pediatric Cardiology. 2020;13(2):130-5.
